Image: Laura Bratton, Photos: Post Consumer Brands (press release), Justin Sullivan (Getty Images) Rappers Snoop Dogg and Master P may have already made their mark in hip hop, but their real dream was to make cereal. Yes, cereal. Or at least that’s what the two performers (who are worth $160 million and $200 million, respectively) … Read more
Data from poison control centers from around the country show a large increase in calls in connection with a weight-loss and diabetes drug. America’s Poison Centers reports around 3,000 calls in relation to semaglutide — an anti-diabetic medication — between January and November of this year, according to CNN. That is a rise of over … Read more
Americans are increasingly calling poison control centers over semaglutide, the active ingredient in popular weight loss drugs Ozempic and Wegovy. Most of these calls appear to concern potential overdoses of semaglutide and might be tied to a rise in compounded versions of the drug, which aren’t tested for their safety and can come in doses … Read more
Key Points The Health Care Select Sector SPDR Fund has dropped 3.81% in the last month and 8.03% in the past three months. Pharmaceuticals’ weak earnings reports are contributing to the healthcare sector’s recent underperformance. Bristol Myers Squibb, AbbVie, Merck, Johnson & Johnson, and Pfizer all traded below previous highs due to earnings concerns. 5 … Read more
Novo Nordisk recently announced that its FLOW trial, which studies Ozempic (semaglutide) in diabetic patients with chronic kidney disease (CKD), will come to a halt almost one year prior to the planned completion date, as interim results alone were sufficient in proving that the treatment was successful in treating kidney failure in this patient group. … Read more
The slim version A year ago, most people had never heard the word “Ozempic.” Now, the weight loss “wonder drug” and a nearly identical prescription called Wegovy are on the tip of everyone’s tongues. The weekly injectable, initially developed to treat Type 1 diabetes, has been hailed as a “breakthrough,” a “game-changer,” “revolutionary,” and, yes, … Read more
America’s Food Giants Confront the Ozempic Era The Wall Street Journal Source link credite
To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit Card Debts The Wall Street Journal Source link
A Louisiana woman sued the manufacturers of popular weight loss drugs Ozempic and Mounjaro on Wednesday, alleging that the drug makers failed to warn patients about the risk of severe gastrointestinal problems. The lawsuit claims that Novo Nordisk and Eli Lilly, the respective manufacturers of Ozempic and Mounjaro, “downplayed the severity of the gastrointestinal events” … Read more